Clarendon Fund Managers | Cumulus Neuroscience involved in new diagnostics assessment, Fastball EEG.
2471
post-template-default,single,single-post,postid-2471,single-format-standard,qode-listing-1.0.1,qode-social-login-1.0,qode-news-1.0,qode-quick-links-1.0,qode-restaurant-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,qode-content-sidebar-responsive,qode-theme-ver-12.1,qode-theme-bridge,bridge,wpb-js-composer js-comp-ver-5.4.2,vc_responsive
 

Cumulus Neuroscience involved in new diagnostics assessment, Fastball EEG.

25 Aug Cumulus Neuroscience involved in new diagnostics assessment, Fastball EEG.

Posted at 10:27h in Uncategorised by

As quicker, more accurate ways to detect dementia becomes ever more urgent, Cumulus Neuroscience Ltd. has teamed up with the Universities of Bath and Bristol in the U.K. to further develop the Fastball electroencephalogram (EEG) test, a diagnostic test for earlier detection of Alzheimer’s dementia. With one in three people born in the U.K. today likely to develop dementia at some point in their lives, early diagnosis and treatment are essential for them to plan for their future.

Print page